Macrophages participate in doxorubicin-induced cardiac damage

Vascul Pharmacol. 2024 Jun:155:107309. doi: 10.1016/j.vph.2024.107309.

Authors

Federica Andrea Cerasuolo¹, Jessica Gambardella¹, Gaetano Santulli², Antonella Fiordelisi¹, Xujun Wang², Nella Prevete¹, Edoardo Sommella³, Roberta Avvisato¹, Antonietta Buonaiuto¹, Giovanna Giuseppina Altobelli¹, Michele Ciccarelli³, Carmine Morisco¹, Junichi Sadoshima⁴, Guido Iaccarino¹, Daniela Sorriento¹

Affiliations

¹ Department of Advanced Biomedical Science, University of Naples Federico II, 80138 Naples, Italy.
² Albert Einstein College of Medicine, 10461 New York, USA.
³ Department of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy.
⁴ Rutgers New Jersey Medical School, 07101-1709 Newark, USA.

PMID: 38985612
DOI: 10.1016/j.vph.2024.107309

No abstract available

MeSH terms

Animals
Antibiotics, Antineoplastic / adverse effects
Cardiotoxicity
Doxorubicin* / adverse effects
Humans
Macrophages* / drug effects
Macrophages* / metabolism
Myocardium / metabolism
Myocardium / pathology
Myocytes, Cardiac / drug effects
Myocytes, Cardiac / metabolism
Myocytes, Cardiac / pathology

Substances

Doxorubicin
Antibiotics, Antineoplastic